A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer

Elevated expression of the chemokine receptor CCR4 in tumors is associated with poor prognosis in several cancers. Here, we have determined that CCR4 was highly expressed in human renal cell carcinoma (RCC) biopsies and observed abnormal levels of CCR4 ligands in RCC patient plasma. An antagonistic...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Invest
Главные авторы: Berlato, Chiara, Khan, Moddasar N., Schioppa, Tiziana, Thompson, Richard, Maniati, Eleni, Montfort, Anne, Jangani, Maryam, Canosa, Monica, Kulbe, Hagen, Hagemann, Urs B., Duncan, Alexander R., Fletcher, Laura, Wilkinson, Robert W., Powles, Thomas, Quezada, Sergio A., Balkwill, Frances R.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Clinical Investigation 2017
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330727/
https://ncbi.nlm.nih.gov/pubmed/28134623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI82976
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы